Jane Street’s ARK Genomic Revolution ETF ARKG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$27.3M Buy
1,032,100
+477,400
+86% +$14M ﹤0.01% 1520
2025
Q4
$16.1M Sell
554,700
-85,600
-13% -$2.57M ﹤0.01% 1808
2025
Q3
$17.8M Buy
640,300
+258,800
+68% +$6.54M ﹤0.01% 1767
2025
Q2
$9.29M Buy
381,500
+4,900
+1% +$107K ﹤0.01% 2235
2025
Q1
$7.82M Buy
376,600
+174,300
+86% +$4.38M ﹤0.01% 2311
2024
Q4
$4.76M Sell
202,300
-100,000
-33% -$2.46M ﹤0.01% 2716
2024
Q3
$7.74M Buy
302,300
+3,900
+1% +$99.3K ﹤0.01% 2221
2024
Q2
$7.01M Sell
298,400
-455,000
-60% -$11.5M ﹤0.01% 2489
2024
Q1
$21.7M Buy
753,400
+388,700
+107% +$11.7M ﹤0.01% 1125
2023
Q4
$12M Buy
364,700
+214,900
+143% +$5.84M ﹤0.01% 1761
2023
Q3
$4.17M Buy
149,800
+94,200
+169% +$3.08M ﹤0.01% 2875
2023
Q2
$1.9M Sell
55,600
-33,100
-37% -$1.04M ﹤0.01% 4240
2023
Q1
$2.67M Buy
88,700
+5,700
+7% +$177K ﹤0.01% 3344
2022
Q4
$2.34M Sell
83,000
-92,500
-53% -$2.94M ﹤0.01% 3621
2022
Q3
$5.77M Sell
175,500
-167,200
-49% -$6.14M ﹤0.01% 2385
2022
Q2
$10.8M Sell
342,700
-499,700
-59% -$17.5M ﹤0.01% 1653
2022
Q1
$38.7M Buy
842,400
+91,400
+12% +$4.36M 0.01% 814
2021
Q4
$46M Sell
751,000
-145,200
-16% -$10M 0.02% 690
2021
Q3
$67M Buy
896,200
+64,100
+8% +$5.38M 0.02% 479
2021
Q2
$77M Buy
832,100
+325,800
+64% +$27.7M 0.03% 386
2021
Q1
$44.9M Buy
506,300
+275,100
+119% +$27.3M 0.02% 532
2020
Q4
$21.6M Buy
+231,200
New +$18.4M 0.01% 828

Other funds holding ARKG

Jane Street's ARKG Position: Q1 2026 in Review

Jane Street reduced its ARK Genomic Revolution ETF (ARKG) stake by 83% in Q1 2026, selling an estimated $14.2M and leaving 96,335 shares worth $2.55M. The position accounts for ﹤0.01% of the portfolio, ranked #4647.

Jane Street first reported a position in ARKG in Q4 2014 and has held it in 41 quarters since. The position peaked at $71.8M in Q4 2020. 218 funds tracked by Wall St. Rank hold ARKG as of Q1 2026.

  • Jane Street held 96,335 shares of ARK Genomic Revolution ETF worth $2.55M as of Q1 2026.
  • Jane Street sold 484,079 ARK Genomic Revolution ETF shares in Q1 2026, an estimated $14.2M.
  • ARK Genomic Revolution ETF made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #4647 holding.
  • Jane Street first reported a position in ARK Genomic Revolution ETF in Q4 2014 and has held it in 41 quarters since.
  • Jane Street's ARK Genomic Revolution ETF position peaked at $71.8M in Q4 2020.
  • 218 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.